Capvizr
News · All summaries
Healthcare & Life Sciences
Hexagon Bio
Series C$62 million
RoundSeries C
Amount$62 million
LeadColumn Group
HQMenlo Park, United States
DateOctober 23, 2026
THE DEAL, AT A GLANCE

Hexagon Bio

From the announcement
Who is involvedBacked by Column Group, Nextech Invest, Deviation Capital, 8VCFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedHexagon Bio raised $62M Series C, announced 2026-10-23From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Hexagon Bio · Financing Record

Explore source-linked visual explanations for Hexagon Bio. Unsupported claims are withheld while source review continues.

Record 14587 · Recorded date: 2026-10-23

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime